Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature

Dapsone is a commonly used second line drug for prophylaxis of pneumocystis jirovecii pneumonia (PJP) in immunocompromised patients. Oxidant hemolysis, caused by dapsone’s metabolite hydroxylamine, is a common side effect, and screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency is reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Scott M, Geetha, Duvuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305048/
https://www.ncbi.nlm.nih.gov/pubmed/25628986
http://dx.doi.org/10.1186/s40064-015-0816-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305048/
https://www.ncbi.nlm.nih.gov/pubmed/25628986
http://dx.doi.org/10.1186/s40064-015-0816-y

Ejemplares similares